U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07528066) titled 'Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC' on April 07.
Brief Summary: The goal of this observational study is to learn whether tumor and nodal downstaging after neoadjuvant chemo-immunotherapy is associated with better surgical outcomes in patients with clinical stage IIB-III non-small cell lung cancer (NSCLC) undergoing robotic-assisted thoracic surgery. The main question it aims to answer is:
Is downstaging after neoadjuvant chemo-immunotherapy associated with better surgical outcomes in patients with stage IIB-III NSCLC undergoing robotic-assisted surgery?
Participants with resectable or po...